NMTC Share Price Performance
US$0.90
-0.12 (-11.49%)
59.4% undervalued intrinsic discount
US$2.23
Fair Value
Price US$0.90
AnalystConsensusTarget US$2.23
AnalystLowTarget US$1.45
Fair ValueUS$2.23
Share Pricen/a
NeuroOne Medical Technologies Corporation Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
NMTC Community Narratives
AN
Fair Value US$2.23 59.4% undervalued intrinsic discount
Brain Therapy Delivery And Pain Treatment Expansion May Support Long Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$1.45 37.7% undervalued intrinsic discount
Brain Ablation Dependency And Regulatory Delays Will Challenge Neuromodulation Expansion Yet Long-Term Potential Remains
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Brain Therapy Delivery And Pain Treatment Expansion May Support Long Term Upside Potential
Catalysts About NeuroOne Medical Technologies NeuroOne Medical Technologies develops and commercializes advanced minimally invasive electrode and ablation systems for diagnosing and treating neurological conditions and chronic pain. What are the underlying business or industry changes driving this perspective?Read more
6
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$2.23
59.4% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
10.6% p.a.
Profit Margin
12.91%
Future PE
81.24x
Price in 2028
US$1.55
Brain Ablation Dependency And Regulatory Delays Will Challenge Neuromodulation Expansion Yet Long-Term Potential Remains
Catalysts About NeuroOne Medical Technologies NeuroOne Medical Technologies develops and commercializes thin film electrode and RF ablation systems for neurological and pain management indications. What are the underlying business or industry changes driving this perspective?Read more
4
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$1.45
37.7% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
36.43% p.a.
Profit Margin
12.91%
Future PE
51.05x
Price in 2028
US$1.01
Trending Discussion
Recently Updated Narratives
AN
Brain Therapy Delivery And Pain Treatment Expansion May Support Long Term Upside Potential
Fair Value: US$2.23 59.4% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Brain Ablation Dependency And Regulatory Delays Will Challenge Neuromodulation Expansion Yet Long-Term Potential Remains
Fair Value: US$1.45 37.7% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
NeuroOne Medical Technologies Corporation Key Details
About NMTC
- Founded
- n/a
- Employees
- 18
- CEO
- WebsiteView website
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.
